Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+5.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,007
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| 1 |
ConocoPhillips
COP
|
$230M |
| 2 |
Bristol-Myers Squibb
BMY
|
$185M |
| 3 |
WESCO International
WCC
|
$171M |
| 4 |
Gilead Sciences
GILD
|
$158M |
| 5 |
Delta Air Lines
DAL
|
$148M |
Top Sells
| 1 |
MRO
Marathon Oil Corporation
MRO
|
$221M |
| 2 |
3M
MMM
|
$154M |
| 3 |
Marsh & McLennan
MMC
|
$115M |
| 4 |
Johnson & Johnson
JNJ
|
$99M |
| 5 |
Novo Nordisk
NVO
|
$94.6M |
Sector Composition
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Excelerate Energy
EE
$758M
| $756K | ﹤0.01% |
25,000
-25,000
| -50% | -$756K |
|
827
Clean Energy Fuels
CLNE
$546M
| $753K | ﹤0.01% |
+300,000
| New | +$753K |
|
828
Zura Bio
ZURA
$143M
| $750K | ﹤0.01% |
+300,000
| New | +$750K |
|
829
Amplify Junior Silver Miners ETF
SILJ
$2.07B
| $745K | ﹤0.01% |
+75,000
| New | +$745K |
|
|
XHR
830
Xenia Hotels & Resorts
XHR
$1.38B
| $739K | ﹤0.01% |
+49,706
| New | +$739K |
|
831
Bentley Systems
BSY
$16.3B
| $701K | ﹤0.01% |
15,000
+5,000
| +50% | +$234K |
|
832
Patterson-UTI
PTEN
$2.18B
| $661K | ﹤0.01% |
80,000
+10,000
| +14% | +$82.6K |
|
833
Permian Resources
PR
$9.75B
| $647K | ﹤0.01% |
+45,000
| New | +$647K |
|
834
CACI
CACI
$10.4B
| $608K | ﹤0.01% |
1,505
+1,045
| +227% | +$422K |
|
835
Teleflex
TFX
$5.78B
| $606K | ﹤0.01% |
+3,405
| New | +$606K |
|
836
BILL Holdings
BILL
$5.24B
| $594K | ﹤0.01% |
7,013
-52,000
| -88% | -$4.4M |
|
837
Health Catalyst
HCAT
$238M
| $525K | ﹤0.01% |
74,280
-50,000
| -40% | -$354K |
|
838
VYNE Therapeutics
VYNE
$7.62M
| $516K | ﹤0.01% |
+154,134
| New | +$516K |
|
839
Tenax Therapeutics
TENX
$27.4M
| $516K | ﹤0.01% |
83,333
| – | – |
|
840
Kilroy Realty
KRC
$5.05B
| $444K | ﹤0.01% |
+10,970
| New | +$444K |
|
841
AN2 Therapeutics
ANTX
$34.4M
| $431K | ﹤0.01% |
312,615
| – | – |
|
842
Braze
BRZE
$3.5B
| $419K | ﹤0.01% |
+10,000
| New | +$419K |
|
843
Ensysce Biosciences
ENSC
$6.32M
| $407K | ﹤0.01% |
+50,000
| New | +$407K |
|
844
OPAL Fuels
OPAL
$65.5M
| $390K | ﹤0.01% |
115,000
| – | – |
|
845
Alignment Healthcare
ALHC
$3.14B
| $388K | ﹤0.01% |
34,497
+4,497
| +15% | +$50.6K |
|
|
SHMD
846
SCHMID Group
SHMD
$102M
| $385K | ﹤0.01% |
125,000
| – | – |
|
847
Palladyne AI Corp Warrants
PDYNW
$4.21M
| $328K | ﹤0.01% |
427,763
| – | – |
|
848
Flushing Financial
FFIC
$457M
| $300K | ﹤0.01% |
+21,042
| New | +$300K |
|
849
Plumas Bancorp
PLBC
$311M
| $222K | ﹤0.01% |
+4,693
| New | +$222K |
|
|
NPKI
850
NPK International Inc.
NPKI
$887M
| $192K | ﹤0.01% |
25,000
| – | – |
|